Kilitch Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹50 crore and net profit of ₹1.42 crore for the September 2026 quarter.
Kilitch Drugs (NSE: KILITCH) closed at ₹223.81 on 20 Nov 2026, up 23.4% over the past year. Its market capitalisation is ₹782 crore and it trades at 32.5 times earnings.
Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.